ATAP Inclusion/Exclusion and List of Study Sites
Posted on: December 07, 2009
This information was complied from the information provided on clinicaltrials.gov.
To read, please download file by clicking here.
The Official Website of the Acid Maltase Deficiency Association
It is difficult to say what is impossible for the dreams of yesterday are the hopes of today and the reality of tomorrow. - Robert H. Goddard
Get Involved
Your generous contribution will go a long way into improving the quality of life of Pompe Disease Patients worldwide. Donations go towards Pompe Disease Research.
Recently Added Items
- Valerion Initiates VAL-1221 Dosing in Patients with Pompe Disease was posted in News, last July 11, 2017
- GAA Deficiency in Pompe Disease Is Alleviated by Exon Inclusion in iPSC-Derived Skeletal Muscle Cell was posted in Publications, last June 16, 2017
- In Memory of Henri Termeer was posted in News, last May 19, 2017
- Amicus Therapeutics Announces Positive Functional Data from Initial Patients in Phase 1/2 Study was posted in News, last May 15, 2017
- Skeletal muscle metabolism during prolonged exercise in Pompe disease. was posted in Publications, last May 10, 2017
Disclaimer: The AMDA does not endorse any of the products, medications, treatments or information reported herein. The website and its contents is intended for informational purposes, only. We strongly advise that you discuss all medications, treatments, and/or products with your physician.
© 2011 Acid Maltase Deficiency Association
Address: AMDA PO Box 700248
San Antonio, Texas 78270 USA